CRO

Spotlight On... PSI touts its hematology expertise; Wockhardt clears U.K. regulators; Infinity taps Medidata; and much more...

Swiss CRO PSI is headed to this weekend's American Society of Hematology meeting, touting its experience in trials for breakthrough treatments for blood cancers. News

> Indian drug manufacturer Wockhardt said it received U.K. clearance for a troubled production plant in Chikalthana. More

> Infinity Pharmaceuticals ($INFI) enlisted Medidata ($MDSO) to help execute its Phase III cancer trial. Story